A phase I/II study for intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy.

Bibliographic Information

Title
A phase I/II study for intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy.
Author
Nagoshi N, Tsuji O, Kitamura K, Suda K, Maeda T, Yato Y, Abe T, Hayata D, Matsumoto M, Okano H, Nakamura M.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1011694355638762240
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top